Tongrui Liu
Overview
Explore the profile of Tongrui Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
587
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yao X, Liu T, Dong L, Deng X
Sheng Wu Gong Cheng Xue Bao
. 2025 Feb;
41(2):869-880.
PMID: 39989076
() plays an important role in plant branching, while little is known about the roles of this gene in petunias. In this study, was cloned from × cv. Mitchell Diploid,...
2.
Lin H, Blake D, Liu T, Freeman R, Lesinski G, Yang L, et al.
Mol Ther Oncol
. 2024 Sep;
32(4):200868.
PMID: 39346763
Pancreatic cancer is an aggressive malignancy with a 5-year survival rate of 13% that remains refractory to current immunotherapies, such as chimeric antigen receptor (CAR) T cells. These engineered cells...
3.
Wells K, Liu T, Zhu L, Yang L
Nanoscale
. 2024 Sep;
16(38):17699-17722.
PMID: 39257225
Cancer immunotherapy represents a promising targeted treatment by leveraging the patient's immune system or adoptive transfer of active immune cells to selectively eliminate cancer cells. Despite notable clinical successes, conventional...
4.
Zhu L, Zhao Y, Liu T, Chen M, Qian W, Jiang B, et al.
ACS Nano
. 2022 Oct;
16(11):18708-18728.
PMID: 36256454
Upregulation of NADPH oxidases (NOXs) in cancer cells leads to chronic increase in intracellular reactive oxygen species (ROS) and adaptation to a high ROS level for cell survival and, thereby,...
5.
Taliaferro-Smith L, Oberlick E, Liu T, McGlothen T, Alcaide T, Tobin R, et al.
Oncotarget
. 2015 Mar;
6(7):4757-72.
PMID: 25749031
Triple negative breast cancer (TNBC) is a highly metastatic disease that currently lacks effective prevention and treatment strategies. The insulin-like growth factor 1 receptor (IGF1R) and focal adhesion kinase (FAK)...
6.
Liu T, Yacoub R, Taliaferro-Smith L, Sun S, Graham T, Dolan R, et al.
Mol Cancer Ther
. 2011 Jun;
10(8):1460-9.
PMID: 21690228
Triple-negative breast cancers, which lack estrogen receptor, progesterone receptor, and HER2/neu overexpression, account for approximately 15% of breast cancers, but occur more commonly in African Americans. The poor survival outcomes...
7.
Graham T, Yacoub R, Taliaferro-Smith L, Osunkoya A, Odero-Marah V, Liu T, et al.
Breast Cancer Res Treat
. 2009 Nov;
123(1):139-47.
PMID: 19921427
Zinc-finger enhancer binding protein (ZEB1) is a transcription factor involved in the progression of cancer primarily through promoting epithelial to mesenchymal transition (EMT). ZEB1 represses the expression of E-cadherin by...
8.
Hong Y, Liu T, Lee M, Hofacre C, Maier M, White D, et al.
J Food Prot
. 2009 Oct;
72(10):2198-201.
PMID: 19833046
Salmonella continues to cause significant foodborne outbreaks, best illustrated with recent outbreaks associated with peanut butter, raw tomatoes, and serrano peppers. To ascertain the likely source of the outbreak, bacterial...
9.
Ozbay T, Durden D, Liu T, ORegan R, Nahta R
Cancer Chemother Pharmacol
. 2009 Jul;
65(4):697-706.
PMID: 19636556
Purpose: The purpose of the current study is to determine the in vitro cytotoxic effects of the novel pan-PI3-kinase inhibitor SF1126 in HER2-over-expressing breast cancer cells. Methods: Cell proliferation and...
10.
Zhong D, Xiong L, Liu T, Liu X, Liu X, Chen J, et al.
J Biol Chem
. 2009 Jul;
284(35):23225-33.
PMID: 19574224
Recent molecular studies indicate that aerobic glycolysis plays an important role in tumorigenesis and is a valid target for cancer therapy. Although 2-deoxyglucose (2-DG) is well characterized as a glycolytic...